Chemical Structure (Exemestane 01)
Exemestane Tablet
Product Images NDC 0832-0595
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 0832-0595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Exemestane 02)
The given text provides information on the proportion surviving, HR (hazard ratio), and log-rank p-value for Exemestane and Tamoxifen treatments. The treatment was randomized between 213 and 307 participants. The text also shows a graph of the duration of disease-free survival in months. The information is likely a part of a medical or clinical trial report.*
Figure 2 (Exemestane 03)
Principal Display Panel (25 mg Tablet Bottle Label)
Each tablet contains 25mg of the drug Exemestane, USP. The recommended dosage should be obtained from the package insert for full prescribing information. The drug should be stored at 25°C (77°F) with permitted excursions between 16° to 30°C. The tablets should be dispensed in a light-resistant container with child-resistant closure. This drug is produced by Upsher-Smith Laboratories, LLC located in Maple Grove, MN 55369. This drug is available by prescription only in New Zealand and the label was revised on April 2021.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
